( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57



Dr. Basavanna P.L.*, Dr. Niranjan M.R., Albin M. Antony, Annpriya Thampy, Jijo Joji and Joann Mary Jose


Background: CKD is defined as an irreversible condition with abnormalities of kidney structure or function, present for > 3months, with implication of health. Kidney damage includes a wide range of abnormalities and is observed during clinical assessment. GFR is accepted as the overall index of kidney function. It is very difficult to identify CKD in its early stage. Several issues contribute to high prevalence in India. Diabetes and hypertension account for 40%-60% CKD in India. As per Indian Counsel of Medical Research, prevalence of CKD is increased by 6.3%. Due to lifestyle diseases there is a 30% increase in the CKD in US. Smoking, obesity, older age family history also contributes to the development of CKD. In our study male patients with older age are dominant with CKD. Objectives: The main objectives was to assess the compliance and depressive symptoms among the patients receiving polypharmacy in Chronic Kidney Disease. Materials And Methods: Prospective observational analysis of CKD cases admitted to KR Hospital over a period of 6 months from November 2018 to April 2019 was carried out with a sample size of 168. The data obtained was analyzed by using SPSS version 20. Result: Among 168 patients 111 patients were male patients and 57 patients were females. In the study population 77 patients were low adherent to the treatment and 60 patients were moderately adherent and 31 patients were highly adherent. In 168 patients 56 patients were with minimal depressive symptoms (33.3%), 57 patients were with mild depressive symptoms (33.9) and 36 patients with moderate depressive symptoms (21.4%). Only 4 patients were observed with severe depression (2.4%). In the study furosemide was the drug that caused highest incidence of ADR. Conclusion: Our study reveals that most of the patients are with poor adherence to medication. Depressive symptoms are more prevalent in CKD patient. Most of the patients in our study were shown minimal depressive symptoms and incidence of depression was more observed in female patients. In CKD patients depression is unrecognizable in most of the patients. So it is the duty of the pharmacist to make aware the patients about the indication and side effect of the drugs. And also to provide patient counseling to make the society to more adherent to the medication and to prevent depression.

Keywords: Chronic Kidney Disease (CKD), Patient compliance, Depressive symptoms, polypharmacy, Adverse Drug Reaction.

[Full Text Article] [Download Certificate]


  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44



  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.


    FEBRUARY 2024 issue has been successfully launched on 1 FEBRUARY 2024.

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 February 2024 Issue has been Published, Kindly check it on

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia